文献速递主动脉疾病

EVAR长期质量新指标:高于平均胜场(WAA)可区分中心表现并预测未来结局

A novel long-term quality metric for endovascular abdominal aortic aneurysm repair, wins above average, discriminates center performance and predicts future outcomes.
PubMed 文献 · J Vasc Surg · 2026-03-20

研究基于VQI-Medicare链接数据(2010-2015年择期EVAR,随访至2019年),采用类似体育分析法的累积概率指标WAA对198个中心进行风险调整排名。WAA四分位有效区分4年复合结局(死亡、动脉瘤破裂或重大再干预):Q1 44.5% vs Q4 28.8%(P < .001),并在2016-2017年外部人群中验证了预测价值(2年复合结局Q1 22.8% vs Q4 17.0%,P = .002)。

要点

  • WAA可对EVAR中心进行风险调整的长期质量排名,区分4年复合结局。
  • WAA四分位在后续独立时间段仍可预测2年复合结局。
  • 该指标有望用于质量改进和EVAR诊疗基准化。

核心结论

  • WAA是一种新型长期EVAR质量指标,评估主动脉相关聚合结局,可有效区分中心水平表现。

研究设计与样本

  • 回顾性队列研究,使用Vascular Quality Initiative-Medicare链接数据,纳入2010-2015年择期EVAR患者共10,081例,分布于198个中心,随访至2019年。
  • 采用类似体育分析法的累积概率指标WAA,基于主要结局(死亡、重大再干预或动脉瘤破裂的复合终点)生成风险调整、对手术量敏感的中心排名,风险调整使用Cox比例风险模型。
  • 按中心质量四分位(Q1最低至Q4最高)比较患者与中心特征及结局,并评估2010-2015年四分位对2016-2017年结局的预测能力。

主要发现

  • WAA四分位有效区分4年复合结局(死亡、动脉瘤破裂或重大再干预):Q1 44.5% vs Q2 40.4% vs Q3 34.0% vs Q4 28.8%(P < .001)。
  • 各组成部分亦存在差异:死亡(Q1 38% vs Q2 35% vs Q3 28% vs Q4 24%;P < .001)、重大再干预(Q1 13% vs Q2 11% vs Q3 8.5% vs Q4 7.8%;P < .001)、动脉瘤破裂(Q1 3.6% vs Q2 2.0% vs Q3 1.5% vs Q4 1.8%;P < .001)。
  • 2016-2017年,5,153例患者在接受先前定义质量四分位的中心行EVAR,2年复合结局率证实WAA四分位的预测价值:Q1 22.8% vs Q2 21.0% vs Q3 19.6% vs Q4 17.0%(P = .002)。

关键数值与推荐

  • 重大再干预定义为EVAR相关再干预满足以下之一:开放手术再干预、再干预住院超过2晚、或过度血管内再干预负担(3次或以上再干预)。
  • 主要结局为死亡、重大再干预或动脉瘤破裂的复合终点。

临床怎么用

  • WAA可用于EVAR中心的质量改进项目和基准化,识别长期表现较差的中心。
  • 基于WAA的风险调整排名有助于患者转诊和医疗资源分配决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Endovascular abdominal aortic aneurysm repair (EVAR) has low perioperative morbidity and mortality, thereby making long-term outcomes the primary determinant of overall quality. Our aim was to develop a novel, long-term EVAR quality metric capable of discriminating center performance and predicting future outcomes, using previously developed earned-outcomes methods. METHODS: Vascular Quality Initiative-Medicare-linked data were used to examine elective EVAR (2010-2015, with follow-up to 2019). Centers were evaluated based on the primary outcome: a composite of mortality, major reintervention, or aneurysm rupture. Major reintervention was defined as any EVAR-related reintervention that met one of the following criteria: (1) open surgical reintervention, (2) more than two nights of hospital admission for reintervention, or (3) excessive endovascular reintervention burden (three or more reinterventions). Using methods similar to those used in sports analytics, cumulative, probability-based metrics (wins above average, WAA) were calculated to generate risk-adjusted, volume-sensitive center-level rankings based on the primary outcome. Risk adjustment used Cox proportional hazards modeling. Patient and center characteristics and outcomes were compared across center quality quartiles (Q1, lowest quality quartile through Q4, highest quality quartile). The ability of 2010 to 2015 quality quartiles to predict outcomes in a future period (2016-2017) was determined. RESULTS: From 2010 to 2015, the analysis included 10,081 patients treated at 198 centers. WAA quartiles effectively discriminated 4-year composite outcomes of mortality, aneurysm rupture, or major reintervention: Q1 44.5% vs Q2 40.4% vs Q3 34.0% vs Q4 28.8% (P < .001). Quartiles also demonstrated differences in each primary outcome component: mortality (Q1 38% vs Q2 35% vs Q3 28% vs Q4 24%; P < .001), major reintervention (Q1 13% vs Q2 11% vs Q3 8.5% vs Q4 7.8%; P < .001), and aneurysm rupture (Q1 3.6% vs Q2 2.0% vs Q3 1.5% vs Q4 1.8%; P < .001). In 2016 to 2017, 5153 patients underwent EVAR at centers where quality quartiles had been defined from the preceding study period. Two-year rates of composite mortality, aneurysm rupture, or major reintervention confirmed the predictive value of WAA quartiles: Q1 22.8% vs Q2 21.0% vs Q3 19.6% vs Q4 17.0% (P = .002). CONCLUSIONS: WAA is a novel, long-term EVAR quality metric that evaluates aggregate aorta-related outcomes and effectively differentiates center-level performance. This innovative approach has potential applications in quality improvement initiatives and benchmarking of EVAR care delivery.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Jones DW, Scali S, Zheng X, et al. A novel long-term quality metric for endovascular abdominal aortic aneurysm repair, wins above average, discriminates center performance and predicts future outcomes. J Vasc Surg. 2026. PMID: 41866094. doi:10.1016/j.jvs.2026.03.434

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。